Use of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk
1. 系统已在2026-01-21 17:10:06对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1053/j.jvca.2025.08.051
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1053077025007281
其他信息:
出版社: Elsevier BV
作者: Alison V. Grazioli; Michael E. Plazak; Cynthia S. Shen; Thomas M. Scalea; Rishi Kundi; Ramon A. Riojas; Leonid A. Belyayev

